180 related articles for article (PubMed ID: 35476232)
1. Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy.
Maitre E; Cornet E; Debliquis A; Drenou B; Gravey F; Chollet D; Cheze S; Docquier M; Troussard X; Matthes T
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2013-2022. PubMed ID: 35476232
[TBL] [Abstract][Full Text] [Related]
2. BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes.
Yap J; Yuan J; Ng WH; Chen GB; Sim YRM; Goh KC; Teo J; Lim TYH; Goay SM; Teo JHJ; Lao Z; Lam P; Sabapathy K; Hu J
Mol Cancer; 2023 Aug; 22(1):125. PubMed ID: 37543582
[TBL] [Abstract][Full Text] [Related]
3. BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.
Pettirossi V; Santi A; Imperi E; Russo G; Pucciarini A; Bigerna B; Schiavoni G; Fortini E; Spanhol-Rosseto A; Sportoletti P; Mannucci R; Martelli MP; Klein-Hitpass L; Falini B; Tiacci E
Blood; 2015 Feb; 125(8):1207-16. PubMed ID: 25480661
[TBL] [Abstract][Full Text] [Related]
4. Hairy cell leukemia: update and current therapeutic approach.
Salam L; Abdel-Wahab O
Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
[TBL] [Abstract][Full Text] [Related]
5. BRAF mutations in hairy-cell leukemia.
Tiacci E; Trifonov V; Schiavoni G; Holmes A; Kern W; Martelli MP; Pucciarini A; Bigerna B; Pacini R; Wells VA; Sportoletti P; Pettirossi V; Mannucci R; Elliott O; Liso A; Ambrosetti A; Pulsoni A; Forconi F; Trentin L; Semenzato G; Inghirami G; Capponi M; Di Raimondo F; Patti C; Arcaini L; Musto P; Pileri S; Haferlach C; Schnittger S; Pizzolo G; Foà R; Farinelli L; Haferlach T; Pasqualucci L; Rabadan R; Falini B
N Engl J Med; 2011 Jun; 364(24):2305-15. PubMed ID: 21663470
[TBL] [Abstract][Full Text] [Related]
6. New insights in the management of patients with hairy cell leukemia.
Cornet E; Damaj G; Troussard X
Curr Opin Oncol; 2015 Sep; 27(5):371-6. PubMed ID: 26154707
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia.
Chung SS; Kim E; Park JH; Chung YR; Lito P; Teruya-Feldstein J; Hu W; Beguelin W; Monette S; Duy C; Rampal R; Telis L; Patel M; Kim MK; Huberman K; Bouvier N; Berger MF; Melnick AM; Rosen N; Tallman MS; Park CY; Abdel-Wahab O
Sci Transl Med; 2014 May; 6(238):238ra71. PubMed ID: 24871132
[TBL] [Abstract][Full Text] [Related]
8. NFkB is activated by multiple mechanisms in hairy cell leukemia.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Genes Chromosomes Cancer; 2015 Jul; 54(7):418-32. PubMed ID: 25960206
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors.
Basso K; Liso A; Tiacci E; Benedetti R; Pulsoni A; Foa R; Di Raimondo F; Ambrosetti A; Califano A; Klein U; Dalla Favera R; Falini B
J Exp Med; 2004 Jan; 199(1):59-68. PubMed ID: 14707115
[TBL] [Abstract][Full Text] [Related]
10.
Bibi A; Java S; Chaudhary S; Joshi S; Mascerhenas R; Rabade N; Tembhare P; Subramanian PG; Gujral S; Menon H; Khattry N; Sengar M; Bagal B; Jain H; Patkar N
Indian J Pathol Microbiol; 2018; 61(4):532-536. PubMed ID: 30303143
[TBL] [Abstract][Full Text] [Related]
11. Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.
Lakiotaki E; Levidou G; Angelopoulou MK; Adamopoulos C; Pangalis G; Rassidakis G; Vassilakopoulos T; Gainaru G; Flevari P; Sachanas S; Saetta AA; Sepsa A; Moschogiannis M; Kalpadakis C; Tsesmetzis N; Milionis V; Chatziandreou I; Thymara I; Panayiotidis P; Dimopoulou M; Plata E; Konstantopoulos K; Patsouris E; Piperi C; Korkolopoulou P
Sci Rep; 2016 Feb; 6():21252. PubMed ID: 26893254
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations.
Durham BH; Getta B; Dietrich S; Taylor J; Won H; Bogenberger JM; Scott S; Kim E; Chung YR; Chung SS; Hüllein J; Walther T; Wang L; Lu SX; Oakes CC; Tibes R; Haferlach T; Taylor BS; Tallman MS; Berger MF; Park JH; Zenz T; Abdel-Wahab O
Blood; 2017 Oct; 130(14):1644-1648. PubMed ID: 28801450
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature.
Gupta R; Yadav S; Mittal N; Rahman K; Sharma A; Gupta A; Nityan S
J Cancer Res Ther; 2020; 16(1):120-126. PubMed ID: 32362621
[TBL] [Abstract][Full Text] [Related]
14. Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.
Tiacci E; Schiavoni G; Martelli MP; Boveri E; Pacini R; Tabarrini A; Zibellini S; Santi A; Pettirossi V; Fortini E; Ascani S; Arcaini L; Inghirami G; Paulli M; Falini B
Haematologica; 2013 Apr; 98(4):635-9. PubMed ID: 23349307
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment.
Polderdijk MCE; Heron M; Kuipers S; Rijkers GT
Expert Rev Clin Immunol; 2019 Aug; 15(8):857-867. PubMed ID: 31282776
[No Abstract] [Full Text] [Related]
16.
Loscocco GG; Rotunno G; Mannelli L; Mannelli F; Vergoni F; Guglielmelli P; Vannucchi AM
Tumori; 2021 Dec; 107(6):NP28-NP32. PubMed ID: 33430710
[TBL] [Abstract][Full Text] [Related]
17. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
Maitre E; Cornet E; Troussard X
Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
[TBL] [Abstract][Full Text] [Related]
18. BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system.
Naseem S; Gupta O; Binota J; Varma N; Varma S; Malhotra P
Mol Biol Rep; 2020 Jun; 47(6):4365-4372. PubMed ID: 32458259
[TBL] [Abstract][Full Text] [Related]
19. BRAF in the cross-hairs.
Geyer MB; Abdel-Wahab O; Tallman MS
Expert Rev Hematol; 2019 Mar; 12(3):183-193. PubMed ID: 30782032
[TBL] [Abstract][Full Text] [Related]
20. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
